Clarity Pharmaceuticals Ltd.ASX: CU6

Positive guidance from the US FDA on Phase III trial

Oct 14, 2024 at 3:10 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment